Sale of 39,600 Invivyd (NASDAQ: IVVD) shares planned

Rhea-AI Filing Summary

A shareholder of Invivyd (symbol IVVD) has filed a notice of proposed sale of 39,600 shares of common stock, with an aggregate market value of 61,776.00, through Morgan Stanley Smith Barney on or about 02/17/2026 on Nasdaq.

The seller acquired 99,000 common shares on 02/15/2026 upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan as equity compensation. Invivyd had 281,987,033 shares outstanding when this notice was prepared.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	39600	61776.00	281987033	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/15/2026	Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan	Issuer			99000	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing reveal for Invivyd (IVVD)?

The filing shows a shareholder plans to sell 39,600 Invivyd common shares. The planned sale, valued at $61,776, will be executed through Morgan Stanley Smith Barney on or about February 17, 2026, according to the disclosure’s securities information table.

How many Invivyd (IVVD) shares are planned for sale and on which exchange?

The notice covers a proposed sale of 39,600 Invivyd common shares. These shares are expected to be sold on the Nasdaq exchange, with an aggregate market value of $61,776 at the time of the filing, using Morgan Stanley Smith Barney as the broker.

How and when were the Invivyd (IVVD) shares being sold acquired?

The seller acquired 99,000 Invivyd common shares on February 15, 2026. The shares came from vesting of restricted stock units granted under the issuer’s 2021 Equity Incentive Plan, described in the filing as equity compensation, not a cash purchase from another investor.

What broker is handling the planned sale of Invivyd (IVVD) shares?

Morgan Stanley Smith Barney LLC Executive Financial Services will handle the sale. The filing lists its address as 1 New York Plaza, 8th Floor, New York, NY 10004, and identifies Nasdaq as the exchange where the 39,600 Invivyd common shares are planned to be sold.

How many Invivyd (IVVD) shares were outstanding when the notice was prepared?

The disclosure reports 281,987,033 Invivyd common shares outstanding. This figure provides context for the planned sale of 39,600 shares, showing the potential transaction is small compared with the issuer’s total outstanding share count at the time the form was completed.